These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1977322)

  • 41. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of feedback inhibition of insulin secretion in denervated human pancreas.
    Luzi L; Battezzati A; Perseghin G; Bianchi E; Vergani S; Secchi A; La Rocca E; Staudacher C; Spotti D; Ferrari G
    Diabetes; 1992 Dec; 41(12):1632-9. PubMed ID: 1359986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy.
    Miles JM; Wooldridge D; Grellner WJ; Windsor S; Isley WL; Klein S; Harris WS
    Diabetes; 2003 Mar; 52(3):675-81. PubMed ID: 12606508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
    Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
    Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
    Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients.
    Vuorinen-Markkola H; Koivisto VA; Yki-Jarvinen H
    Diabetes; 1992 May; 41(5):571-80. PubMed ID: 1568526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
    Boden G; Chen X
    Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
    Hansen IL; Cryer PE; Rizza RA
    Diabetes; 1985 Aug; 34(8):751-5. PubMed ID: 3894118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of insulin-induced hypoglycaemia on lipolysis rate, lipid oxidation and adipose tissue signalling in human volunteers: a randomised clinical study.
    Voss TS; Vendelbo MH; Kampmann U; Pedersen SB; Nielsen TS; Johannsen M; Svart MV; Jessen N; Møller N
    Diabetologia; 2017 Jan; 60(1):143-152. PubMed ID: 27734104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis.
    Gravholt CH; Møller N; Jensen MD; Christiansen JS; Schmitz O
    J Clin Endocrinol Metab; 2001 May; 86(5):2085-9. PubMed ID: 11344211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.
    Björkman O; Felig P; Wahren J
    Clin Physiol; 1984 Jun; 4(3):227-41. PubMed ID: 6146427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus.
    Fowelin J; Attvall S; von Schenck H; Bengtsson BA; Smith U; Lager I
    Metabolism; 1993 Mar; 42(3):387-94. PubMed ID: 8487660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leucine metabolism in IDDM. Role of insulin and substrate availability.
    Luzi L; Castellino P; Simonson DC; Petrides AS; DeFronzo RA
    Diabetes; 1990 Jan; 39(1):38-48. PubMed ID: 2210059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demonstration of a role for growth hormone in glucose counterregulation.
    De Feo P; Perriello G; Torlone E; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E835-43. PubMed ID: 2567576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
    Dagogo-Jack SE; Craft S; Cryer PE
    J Clin Invest; 1993 Mar; 91(3):819-28. PubMed ID: 8450063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man.
    Keller U; Schnell H; Girard J; Stauffacher W
    Diabetologia; 1984 Feb; 26(2):103-8. PubMed ID: 6143702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.